PAPILLARY THYROID CARCINOMA (PTC) is the most common malignancy originating from the thyroid, and generally shows an indolent character. Abstract. Papillary thyroid carcinoma (PTC) often has poorly differentiated components, and it is discriminated from others and classified as an independent entity in the General Rules for the Description of Thyroid Cancer by Japanese Society of Thyroid Surgery (JSTS). In this study, we compared the prognostic significance between this type of poorly differentiated carcinoma (PDC-JSTS) and our risk classification system based on pre-and intraoperative findings in a series of PTC patients. The 10-year lymph node-and distant organ recurrence-free survival (LN-DFS and DRFS) and cause-specific survival (CSS) of high-risk patients were much poorer than in PDC-JSTS patients. In multivariate analysis, PDC-JSTS independently predicted a poor prognosis, but prognostic impacts for LN-DFS, DRFS, and CSS of high-risk in our risk classification were stronger than those of PDC-JSTS. In conclusion, it is appropriate that PDC-JSTS is defined as a subtype of PTC rather than as an independent entity.
off at 3 cm), extrathyroid extension of primary lesions (corresponding to T4a in UICC TNM classification [1] ), and extranodal tumor extension. Disease-free survival (DFS) and cause-specific survival (CSS) significantly worsened from low-to high-risk.
In contrast, histological findings based on postoperative pathological examination can also reflect the prognosis of PTC patients, and poorly differentiated carcinoma is representative. Since this entity was reported in the 1980s, its definition has been interpreted variously [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] . At present, three types of poorly differentiated carcinoma have been proposed by Japanese Society of Thyroid Surgery (JSTS) [17] , WHO classification [18] , and Torino conference [19] . The incidences of these three types in a series of PTC patients in Japan were 11.1, 0.8, and 0.3%, respectively [20] . In the most recent edition of the General Rules for the Description of Thyroid Cancer by JSTS [17] , cases having a poorly differentiated compartment, a lesion showing trabecular, solid, or insular growth patterns, were separated from PTC and defined as an independent entity, even if only a node metastasis, if detected, were measured on ultrasonography. Chest CT scan was also performed for most patients to evaluate lung metastasis.
Surgery
All patients underwent locally curative surgery for PTC. Nine hundred and ten patients underwent total or near total thyroidectomy, and the remaining 1,032 underwent limited thyroidectomy such as subtotal thyroidectomy, lobectomy with isthmectomy, and isthmectomy. Lymph node dissection was performed in 1,870 patients. All these patients underwent central compartment dissection, and 1,606 of these also underwent modified radical neck dissection. Two underwent upper mediastinal compartment dissection. Extrathyroid extension corresponding to T4a in the UICC TNM classification [1] and extranodal tumor extension were evaluated based on intraoperative findings.
Risk classification based on pre-and intraoperative findings
Risk classification was established as described previously [5] , and is summarized in Table 1 . We classified PTC patients without distant metastasis at initial surgery into three categories according to backgrounds and clinicopathological features based on pre-and intraoperative findings.
Pathological diagnosis of PDC-JSTS
H & E sections of all patients were reviewed by our coauthor (M.H.), who specialized in thyroid pathology. The diagnosis of PDC-JSTS was based on the General Rules for the Description of Thyroid Cancer (6 th edition) [17] . As indicated above, we excluded patients diagnosed with poorly differentiated carcinoma in the WHO classification [18] or Torino conference [19] .
slight amount of such a component is detected.
We previously showed that poorly differentiated carcinoma in JSTS significantly affected disease-free survival (DFS) but not cause-specific survival (CSS) of patients by multivariate analysis [20] . However, our previous series included two other types of poorly differentiated carcinoma and the tall cell variant [21, 22] , another aggressive variant. Furthermore, at that time, our risk classification system had not been established. Therefore, in this study, we compared the prognostic significance for lymph node recurrence, distant recurrence, and carcinoma death between poorly differentiated carcinoma in JSTS, but not in the WHO classification or Torino conference (PDC-JSTS), and our risk classification system based on pre-and intraoperative findings.
Patients and Methods

Patients
We enrolled 1,942 patients who underwent initial and locally curative surgery for PTC without distant metastasis at diagnosis between 1987 and 1996. They consisted of 148 males and 1,794 females, and their ages ranged from 8 to 87 years (average: 43.4 years).
Our exclusion criteria are: 1) presence of other thyroid malignancies, 2) presence of distant metastasis at initial surgery, 3) locally non-curative surgery, 4) pathological diagnosis as poorly differentiated carcinoma in the WHO classification [18] and Torino conference [19] and tall cell variant, and 5) loss to follow-up within 12 months after surgery.
Preoperative evaluation
All patients underwent imaging studies including ultrasonography to evaluate primary lesions and lymph node metastasis. Sizes of primary lesions and lymph Table 4 . LN-RFS and CSS worsened from low-to high-risk. DRFS of intermediate-risk patients did not significantly differ from that of low-risk patients, but DRFS of high-risk patients was significantly poorer than that of intermediate-risk patients. Ten-year LN-RFS rates, DRFS rates, and CSS rates of high-risk patients were 67.2, 85.9, and 88.3%, respectively. We then compared the prognostic value between PDC-JSTS and risk classification by multivariate analysis. All three factors, PDC-JSTS, intermediate-, and high-risk, independently affected LN-RFS of PTC patients, but the p-value of high-risk patients was lower and its hazard ratio was higher than those of PDC-JSTS
Postoperative evaluation of recurrence
We normally follow patients by ultrasonography with chest roentogenography and/or CT scan once or twice per year. Postoperative follow-up periods ranged from 1 to 25.2 years (average: 15.9 years). To date, 172 (8.9%) and 48 patients (2.5%) have shown recurrence to the regional lymph nodes and distant organs such as the lung and bone, respectively. Thirty-two patients (1.6 %) have died of PTC.
Statistical analyses
Fisher's exact test was used for analysis of variables. The Kaplan-Meier method and log rank test were adopted to analyze time-dependent variables. The Cox regression model was also adopted for multivariate analysis. These analyses were performed using StatView-J 5.0. A p-value less than 0.05 was regarded as significant. Table 2 shows the backgrounds and clinicopathological features of 1,942 patients. Of the 1,942 patients, 182 (9.4%) were diagnosed with PDC-JSTS. Based on our risk classification system, as shown in Table 1 , 1,728 (89.0%), 100 (5.1%), and 114 patients (5.9%) were classified into low-, intermediate-, and high-risk, respectively. Table 3 indicates 10-year survival rates of PDC-JSTS and non-PDC-JSTS patients. Ten-year lymph node-recurrence-free survival (LN-RFS) rates, distant-recurrence-free survival (DRFS) rates, and causespecific survival (CSS) rates of PTC patients in PDC-JSTS patients were 83.5, 95.2, and 96.4%, respectively, which were significantly poorer (p < 0.0001) than those of non-PDC-JSTS patients, being 94.3, 98.8, and 99.5%, respectively.
Results
Ten-year survival rates of high-, intermediate-, and between PDC-JSTS and our risk classification system. Our risk classification system was established in 2010 in order to accurately prognose PTC patients [5] . As shown in Table 4 , high-risk patients were more likely to die of PTC than others, and intermediate-risk patients were more likely to show lymph node recurrence, but not distant recurrence, than low-risk patients. CSS of PTC patients worsened with a higher risk, indicating that our risk classification accurately reflects the prognosis of PTC patients. The 10-year LN-RFS, DRFS, and CSS rates of high-risk patients were 67.2, 85.9, and 88.3%, respectively, which were lower than those of PDC-JSTS patients, at 83.5, 95.2, and 96.4%, respectively. In multivariate analysis, PDC-JSTS independently affected patients' prognoses, but their prognostic significance was much lower than that of high-risk, as indicated in Table 5 . In CSS of patients, the prognostic value of PDC-JSTS was even lower than that of intermediate-risk. These findings indicate that, although pathological diagnosis as PDC-JSTS has some prognostic impact, high-risk based on our risk classification system much more intensely affects patients' prognoses. Therefore, it could not be appropriate for PDC-JSTS to be defined as a separate entity from non-PDC-JSTS, as described in the General Rules for the Description of Thyroid Cancer [17] .
Sugitani et al. recently demonstrated that, in a series of patients with differentiated carcinoma, a poorly differentiated component in 10% or more of carcinoma lesions is an important risk factor of patients' survival [23] . However, they analyzed papillary and follicular carcinomas as a single group, despite the fact that the biological characteristics and prognostic factors of the two types of carcinoma greatly differ. The number of patients in their series was smaller than ours, and the average follow-up period (8.2 years) was shorter than ours (15.9 years). Furthermore, it is difficult to accurately evaluate the incidence of poorly differentiated components in carcinoma lesions unless H & E-stained sections of all cut surfaces are carefully examined. These may explain the discrepancy between their and our data.
In conclusion, in a series of PTC patients, PDC-JSTS reflects aggressive characteristics to some extent, but its prognostic significance was lower than high-risk in our risk classification based on pre-and intraoperative findings. Therefore, we conclude that PDC-JSTS is better being defined as a subtype of PTC rather than as an independent entity.
( Table 5 -a). Intermediate-risk did not independently reflect DRFS, but high-risk intensely predicted a poor DRFS. PDC-JSTS was also an independent prognostic factor of DRFS, but its prognostic value was lower than that of high-risk (Table 5-b). All three factors were recognized as independent prognostic factors of CSS (Table 5 -c). However, the prognostic value of PDC-JSTS was lower than that of high-risk and even of intermediate-risk.
Discussion
Although the prevalence of poorly differentiated carcinoma varies by country, prevalences of poorly differentiated carcinoma in thes WHO classification and Torino conference in our previous series were very low, at 0.8 and 0.3%, respectively [20] . However, PDC-JSTS is diagnosed at a higher incidence, because it is diagnosed even when only a minute lesion of a poorly differentiated component is detected. Similar to other types, PDC-JSTS is also defined as an independent entity and differentiated from PTC in the General Rules for the Description of Thyroid Cancer, even though most lesions are diagnosed as conventional PTC [17] .
In this study, we compared the prognostic value 
